0001493152-24-046991.txt : 20241120 0001493152-24-046991.hdr.sgml : 20241120 20241120163005 ACCESSION NUMBER: 0001493152-24-046991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241118 FILED AS OF DATE: 20241120 DATE AS OF CHANGE: 20241120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Charles Faith L. CENTRAL INDEX KEY: 0001853985 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41245 FILM NUMBER: 241480775 MAIL ADDRESS: STREET 1: ABEONA THERAPEUTICS INC. STREET 2: 1330 AVENUE OF THE AMERICAS - FLOOR 33 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONDUIT PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0001896212 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 873272543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4851 TAMIAMI TRAIL NORTH STREET 2: SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 BUSINESS PHONE: (646) 491 9132 MAIL ADDRESS: STREET 1: 4851 TAMIAMI TRAIL NORTH STREET 2: SUITE 200 CITY: NAPLES STATE: FL ZIP: 34103 FORMER COMPANY: FORMER CONFORMED NAME: Murphy Canyon Acquisition Corp. DATE OF NAME CHANGE: 20211130 4 1 ownership.xml X0508 4 2024-11-18 0 0001896212 CONDUIT PHARMACEUTICALS INC. CDT 0001853985 Charles Faith L. 4581 TAMIAMI TRAIL NORTH, SUITE 200 NAPLES FL 34103 1 0 0 0 0 Common Stock 2024-11-18 4 A 0 75000 A 75000 D Common Stock 2024-11-18 4 A 0 266594 0.0919 A 341594 D The shares are fully vested and were granted under the Issuer's 2023 Stock Incentive Plan. Represents shares issued in lieu of $24,500 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program. /s/ Faith L. Charles 2024-11-20